Get the Stockscreener App
0.625
11.31%
-0.0797
Pre-market:
.64
0.015
+2.40%
Enveric Biosciences Inc stock is traded at $0.625, with a volume of 407.08K.
It is down -11.31% in the last 24 hours and down -32.13% over the past month.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
See More
Previous Close:
$0.7047
Open:
$0.693
24h Volume:
407.08K
Relative Volume:
1.10
Market Cap:
$2.03M
Revenue:
-
Net Income/Loss:
$-15.08M
P/E Ratio:
-0.0974
EPS:
-6.42
Net Cash Flow:
$-11.56M
1W Performance:
-9.73%
1M Performance:
-32.13%
6M Performance:
-46.58%
1Y Performance:
-90.45%
1-Day Range:
$0.625
$0.70
1-Week Range:
$0.625
$0.7277
52-Week Range:
$0.5606
$8.325
Enveric Biosciences Inc Stock (ENVB) Company Profile
Name
Enveric Biosciences Inc
Sector
Industry
Phone
239-302-1707
Address
4851 TAMIAMI TRAIL N, SUITE 200, NAPLES
Compare ENVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENVB
Enveric Biosciences Inc
|
0.625 | 4.38M | 0 | -15.08M | -11.56M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Enveric Biosciences Inc Stock (ENVB) Latest News
Visual trend scoring systems applied to Enveric Biosciences Inc.Inflation Watch & Real-Time Price Movement Reports - newser.com
Using AI based signals to follow Enveric Biosciences Inc.Market Growth Summary & Expert Curated Trade Ideas - newser.com
When is the best time to exit Enveric Biosciences Inc.IPO Watch & Stepwise Entry and Exit Trade Signals - newser.com
How Enveric Biosciences Is Prepping For Its First IND - Clinical Leader
Can Enveric Biosciences Inc. hit a new high this monthWeekly Stock Summary & Expert Approved Momentum Trade Ideas - newser.com
Will Enveric Biosciences Inc. bounce back from current support2025 Historical Comparison & Consistent Growth Stock Picks - newser.com
Is Enveric Biosciences Inc. trending in predictive chart modelsTrade Risk Assessment & High Win Rate Trade Alerts - newser.com
How Enveric Biosciences Inc. stock compares to growth peersDollar Strength & Consistent Growth Equity Picks - newser.com
Weiss Ratings Reiterates “Sell (E+)” Rating for Enveric Biosciences (NASDAQ:ENVB) - Defense World
Enveric Biosciences Inc SLZ Stock Analysis and ForecastProtective Put Strategies & Consistent Triple Returns - earlytimes.in
Will Enveric Biosciences Inc. (SLZ) stock remain on Wall Street radar2025 Analyst Calls & Fast Entry High Yield Stock Tips - newser.com
Published on: 2025-10-06 00:31:49 - newser.com
What moving averages say about Enveric Biosciences Inc.Trade Volume Summary & Verified Swing Trading Watchlist - newser.com
Can Enveric Biosciences Inc. (SLZ) stock survive global slowdown2025 Major Catalysts & Safe Capital Growth Trade Ideas - newser.com
Why analysts recommend Enveric Biosciences Inc. (SLZ) stockBond Market & Consistent Profit Trade Alerts - newser.com
Is it too late to sell Enveric Biosciences Inc.Trade Entry Report & Safe Capital Growth Plans - newser.com
What hedge fund moves indicate for Enveric Biosciences Inc. (SLZ) stockPortfolio Risk Summary & High Win Rate Trade Tips - newser.com
Enveric Biosciences (ENVB) Achieves Key Manufacturing Milestones for EB-003 - GuruFocus
Enveric Biosciences (ENVB) Advances Development of Lead Candidat - GuruFocus
Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials - Investing News Network
Enveric Biosciences advances manufacturing of depression drug candidate By Investing.com - Investing.com Canada
Enveric Biosciences (NASDAQ:ENVB) Shares Up 3.5% – Here’s Why - Defense World
Is Enveric Biosciences Inc SLZ a good long term investmentGlobal Trade Effects & Free Get Breakthrough Ideas - earlytimes.in
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Applying Wyckoff theory to Enveric Biosciences Inc. stockWeekly Trend Report & AI Enhanced Execution Alerts - newser.com
Published on: 2025-09-28 22:43:18 - newser.com
Published on: 2025-09-27 05:27:52 - newser.com
Published on: 2025-09-26 11:36:04 - newser.com
What analysts say about Enveric Biosciences Inc stockStock Split Announcements & Free Daily Market Summary and Trend Reports - Early Times
Breakouts Watch: Can Enveric Biosciences Inc reach all time highs this yearWeekly Trend Recap & Community Consensus Picks - خودرو بانک
Published on: 2025-09-19 21:11:04 - خودرو بانک
Enveric Biosciences raises $2.2 million through warrant exercise - Investing.com
Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds - PharmiWeb.com
Enveric Biosciences raises $2.2 million through warrant exercise By Investing.com - Investing.com UK
Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds - BioSpace
Enveric Biosciences Inc Stock (ENVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):